736.full.pdf
1.3 MB
π2019 update of the EULAR recommendations for the treatment of systemic lupus erythematosus(SLE)π
@guidelines
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
@guidelines
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
πDiagnosis and management of diarrhea in acutely ill patientsπ
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
CAG_CPG_for_Management_of_IBS_JCAG_Jan2019.pdf
1.1 MB
πCanadian Association of Gastroenterology CIinical Practice Guideline for the management of Irritable Bowel Syndrome (IBS), 2018π
πΈMedical Guidelines‡οΈ
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
πΈMedical Guidelines‡οΈ
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
πColorectal cancer guideline recommendations for symptomatic patientsπ
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
776.full.pdf
904.4 KB
πDiagnosis and management of acute lower gastrointestinal bleeding, British Society of Gastroenterology, 2019π
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
πCURB-65 is a clinical prediction rule that has been validated for predicting mortality in community-acquired pneumonia & infection of any siteπ
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
πCOPD management, 2019π
Classification of airflow limitation severity in COPD (based on post-bronchodilator FEV1)
In patients with FEV1/FVC < 0.70:
πΈGOLD 1βmild: FEV1β₯ 80% predicted
πΈGOLD 2βmoderate: 50% β€ FEV1 < 80% predicted
πΈGOLD 3βsevere: 30% β€ FEV1 < 50% predicted
πΈGOLD 4βvery severe: FEV1 < 30% predicted
@guidelines
Classification of airflow limitation severity in COPD (based on post-bronchodilator FEV1)
In patients with FEV1/FVC < 0.70:
πΈGOLD 1βmild: FEV1β₯ 80% predicted
πΈGOLD 2βmoderate: 50% β€ FEV1 < 80% predicted
πΈGOLD 3βsevere: 30% β€ FEV1 < 50% predicted
πΈGOLD 4βvery severe: FEV1 < 30% predicted
@guidelines
Approach to community-acquired pneumonia (CAP) in adults
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
draft_guideline_clinical_investigation.pdf
331.8 KB
πGuideline on clinical investigation of medicinal products for the treatment of gout, 2019π
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA
https://t.me/joinchat/AAAAAEOnUb4Ecxn8gTkOrA